Sana Biotechnology Inc
(SANA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 253,029 | 433,670 | 675,140 | 750,687 | 124,806 |
| Marketable Securities | 297,967 | 170,041 | 177,696 | 209,550 | 253,458 |
| TOTAL | $558,101 | $612,845 | $860,340 | $967,474 | $384,467 |
| Non-Current Assets | |||||
| PPE Net | 65,464 | 63,445 | 58,670 | 50,986 | 46,775 |
| Investments And Advances | 195,881 | 262,401 | 77,934 | 21,627 | 33,731 |
| Intangibles | 199,822 | 199,822 | 199,822 | 199,822 | 199,822 |
| Other Non-Current Assets | 110,139 | 94,238 | 63,071 | 64,557 | 65,501 |
| TOTAL | $571,306 | $619,906 | $399,497 | $336,992 | $345,829 |
| Total Assets | $1,129,407 | $1,232,751 | $1,259,837 | $1,304,466 | $730,296 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,219 | 3,947 | 3,704 | 4,258 | 2,253 |
| Accrued Expenses | 31,475 | 33,102 | 28,124 | 21,982 | 25,486 |
| Other current liabilities | 56,382 | 48,459 | 5,000 | 5,000 | N/A |
| TOTAL | $99,235 | $92,010 | $42,832 | $35,150 | $31,451 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 301,670 | 310,656 | 311,108 | 387,333 | 1,120,029 |
| TOTAL | $301,670 | $310,656 | $311,108 | $387,333 | $1,120,029 |
| Total Liabilities | $400,905 | $402,666 | $353,940 | $422,483 | $1,151,480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 189,543 | 188,833 | 187,891 | 187,676 | N/A |
| Common Shares | 18 | 18 | 18 | 18 | 2 |
| Retained earnings | -785,360 | -674,629 | -591,366 | -610,049 | -429,432 |
| Other shareholders' equity | -1,366 | -82 | 13 | 56 | 30 |
| TOTAL | $728,502 | $830,085 | $905,897 | $881,983 | $-421,184 |
| Total Liabilities And Equity | $1,129,407 | $1,232,751 | $1,259,837 | $1,304,466 | $730,296 |